En Es
Categories

Industry News

Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases

By HospiMedica International staff writers
23 Jun 2022

Image: Global hospital microbiology testing market driven by increasing prevalence of chronic diseases (Photo courtesy of Pexels)

Manufacturers and players in the global hospital microbiology testing market offer various types of tests, including fungal, viral, and bacterial, as well as instruments and consumables to their end users, i.e. hospitals and clinics. Some of the leading procedures adopted in the global hospital microbiology testing market include microscopy, molecular diagnostics, microbial culture, and biochemical tests. Among the various segments, the respiratory diseases segment leads the global hospital microbiology testing market in terms of demand, owing to the increasing prevalence of asthma as well as the reduction in air quality, causing various respiratory illnesses among the general population globally. Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.


These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company.


Increasing availability as well as efficacy of various anti-viral treatment therapeutics, aimed at the treatment of disorders such as gingivitis, COPD or chronic pulmonary obstructive disease, and periodontitis, among others, is driving the growth of the global hospital microbiology testing market. Furthermore, the increasing prevalence of various sexually transmitted infections is also generating high demand in the global hospital microbiology testing market. As a result, an increase in awareness related to sex and sexuality in various emerging countries is contributing to the market growth. Additionally, growing investments aimed at furthering microbiology testing solutions and relevant equipment is expected to support the development of the global hospital microbiology testing market over the coming years.


Geographically, North America holds the largest share of the global hospital microbiology testing market, mainly due to the increasing prevalence of various chronic as well as acute diseases, presence of well-established and technology-enabled healthcare infrastructure, and rising demand for technologically-advanced and accurate diagnostic testing capabilities in the region. Europe holds the second-largest share of the global hospital microbiology testing market, although the emerging nations in Asia Pacific are expected to provide lucrative growth and expansion opportunities for market growth over the coming years. The growing importance of medical tourism, new and favorable reimbursement policies and tax benefits are propelling the growth of the hospital microbiology testing market in the Asia Pacific region.


Related Links:
Transparency Market Research 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

05 Aug 2022
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments.
Read More
04 Aug 2022
Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure
The global capsule endoscopy system market is expanding at a rapid pace due to the rising demand for the procedure using minimally invasive diagnostic techniques, increase in the introduction of technologically advanced capsules, growth in the geriatric population, and rising prevalence of cancer around the world.
Read More
02 Aug 2022
PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics
PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.
Read More
31 Jul 2022
Labcorp to Spin Off Clinical Development Business
LabCorp Diagnostics (Burlington, NC, USA) has announced that its board of directors has authorized the company to pursue a spin-off of its wholly owned Clinical Development business to shareholders through a tax-free transaction.
Read More
31 Jul 2022
IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics
The IFCC is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive, contributing to its mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.
Read More
27 Jul 2022
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022.
Read More
25 Jul 2022
Registration Opens for RSNA 2022
Registration is now open for the Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) 108th Scientific Assembly and Annual Meeting to be held at McCormick Place Chicago, Nov. 27 – Dec. 1, 2022.
Read More
25 Jul 2022
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) and ELITechGroup S.p.A. (Puteaux, France) have entered into a strategic partnership for monkeypox virus testing across Europe.
Read More
20 Jul 2022
GE's Healthcare Business to Be Named GE HealthCare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions